{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-23-000029","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.869346+00:00","generated_at":"2026-06-12T05:24:53.522650+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ICU Medical Q2 revenue $549.3M (-2% YoY); adjusted EPS $1.88 vs $1.37; narrows FY23 guidance","bullets":["Revenue $549.3M vs $561.0M YoY; GAAP gross margin improved to 35% from 30%.","GAAP net loss $(9.9)M ($(0.41)/share) vs $(7.5)M ($(0.31)/share) YoY.","Adjusted diluted EPS $1.88 vs $1.37; adjusted EBITDA $98.1M vs $84.7M.","Company narrows fiscal year 2023 guidance ranges for revenue and adjusted EPS."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-23-000029","json":"https://secwatch.observer/filing/0000883984-23-000029.json","markdown":"https://secwatch.observer/filing/0000883984-23-000029.md","text":"https://secwatch.observer/filing/0000883984-23-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000029/0000883984-23-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000029/icui-20230807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T05:24:53.522650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}